We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HALL
13326
DELISTED
Hallmark Financial Services, Inc.
HALL
$44K ﹤0.01%
1,201
-36
-3% -$1.53K
SPPI
13327
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$44K ﹤0.01%
20,335
-131,339
-87% -$359K
JP
13328
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
$44K ﹤0.01%
+41,832
New +$55.8K
KURIW
13329
DELISTED
Alkuri Global Acquisition Corp Warrant
KURIW
$44K ﹤0.01%
30,985
-124,217
-80% -$185K
ARMP icon
13330
Armata Pharmaceuticals
ARMP
$167M
$43K ﹤0.01%
11,783
+910
+8% +$3.46K
AYTU icon
13331
PUT
AYTU BioPharma
AYTU
$25.5M
$43K ﹤0.01%
745
-670
-47% -$50.3K
EPOW icon
13332
E-Power Inc
EPOW
$20.6M
$43K ﹤0.01%
+18,830
New +$50.2K
OXSQ icon
13333
Oxford Square Capital
OXSQ
$157M
$43K ﹤0.01%
10,583
-8,786
-45% -$39.9K
PXJ icon
13334
CALL
Invesco Oil & Gas Services ETF
PXJ
$67.1M
$43K ﹤0.01%
2,440
-2,040
-46% -$34.2K
DVLT
13335
CALL
Datavault AI
DVLT
$272M
$43K ﹤0.01%
+1
New +$50K
NEPT
13336
PUT
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$43K ﹤0.01%
51
-41
-45% -$43.3K
IMV
13337
DELISTED
IMV Inc. Common Shares
IMV
$43K ﹤0.01%
2,590
+1,136
+78% +$19.6K
SIOX
13338
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$43K ﹤0.01%
19,800
-26,600
-57% -$57.8K
QUMU
13339
PUT
DELISTED
Qumu Corp.
QUMU
$43K ﹤0.01%
17,400
-19,700
-53% -$52.3K
HMCOW
13340
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$43K ﹤0.01%
+40,502
New +$42.8K
ZVO
13341
DELISTED
Zovio Inc. Common Stock
ZVO
$43K ﹤0.01%
17,971
-4,212
-19% -$10.4K
PHAS
13342
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$43K ﹤0.01%
13,907
-26,477
-66% -$88.4K
PBLA
13343
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$43K ﹤0.01%
+1
New +$58.5K
BXRX
13344
CALL
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$43K ﹤0.01%
54
-51
-49% -$44.4K
TLGT
13345
DELISTED
Teligent, Inc
TLGT
$43K ﹤0.01%
108,162
-195,454
-64% -$85.5K
AVX
13346
Avax One Technology Ltd
AVX
$23.5M
0
GTE icon
13347
CALL
Gran Tierra Energy
GTE
$325M
$42K ﹤0.01%
5,650
+220
+4% +$1.33K
HEPA
13348
CALL
DELISTED
Hepion Pharmaceuticals
HEPA
$42K ﹤0.01%
28
-77
-73% -$123K
MRKR icon
13349
PUT
Marker Therapeutics
MRKR
$19M
$42K ﹤0.01%
2,470
-2,280
-48% -$46.7K
PRPO icon
13350
PUT
Precipio
PRPO
$42M
$42K ﹤0.01%
740
-1,055
-59% -$66.1K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.